Reimagining the path from scientific discovery to real-world solutions

The Ellison Institute of Technology combines cutting-edge research and commercial capability, to drive scientific breakthroughs and create sustainable, ethical companies.

Led by our President, Professor Sir John Bell, the distinguished immunologist and former Regius Professor of Medicine at the University of Oxford, we are bringing together cross-cutting capabilities and talent spanning synthetic biology, clinical medicine, plant science, sustainable energy, public policy, and more.

These efforts are underpinned by substantial computing capability enabled by Oracle, a world-class Artificial Intelligence team, and a Scholars programme to develop future generations of the world’s finest scientists.  

We aim to develop end-to-end solutions to some of society’s enduring challenges, from scientific breakthrough to commercial products at global scale. Our work is guided by four Humane Endeavours: Health & Medical Science; Food Security & Sustainable Agriculture; Climate Change & Clean Energy; and Government Innovation in the Era of AI.

All our programs support one or more of these Humane Endeavours, led by world-leaders in the field. Over time, the programs will manifest themselves as commercial companies for public good. We will commit long-term funding to scale these entities, reinvesting the profits in EIT to ensure self-sufficiency and stimulate further scientific discovery.

We believe transformative innovation can only be delivered if we break down the silos between scientists, engineers, clinicians, scholars, technologists, policymakers, and entrepreneurs.

Interdisciplinary collaboration is embedded into everything we do. We will facilitate sustained exploration of high-risk, high-reward and high-impact science, combined with an ambitious vision and patient capital funding.

Humanity faces a number of significant and pressing challenges that threaten the health of the planet and those who live on it. The scale and complexity of the challenges we face as a society - whether they be the need to engineer better medicines, improve food security, or tackle climate change - call for a new approach to problem-solving.

While engineering, science and technology has been unlocking new solutions for years, the current systems are siloed. They often struggle to deliver solutions at the scale required to distribute them equitably across the globe, or sustain them over time. To solve our most pressing and enduring challenges, we must get better at translating science into global impact.

By empowering the best talent, harnessing the potential of AI, offering a unique working environment, and providing sustained investment over time, we believe we can accelerate scientific discovery to deliver the necessary transformations at scale.

Our model provides a bold new paradigm for how discovery science can drive societal impact.

EIT is based across the Oxford Science Park and Littlemore, where we are building a world-class research and development facility. Set for completion in 2027, the state-of-the-art campus will include 300,000 sq ft of research laboratories, an oncology and preventative care clinic, plus educational and meeting spaces. Together, they create the perfect environment for our experts to take ground-breaking ideas from research to broad implementation.

When scientists work in close proximity, the exchange of ideas becomes seamless, leading to more interdisciplinary research. We are designing that way of working into the fabric of the campus and the culture we are building.